The parasympathetic reduction in heart rate involves the sequential activation of m2 muscarinic cholinergic receptors (m 2 Rs), pertussis toxin-sensitive (Gi/o) heterotrimeric G proteins, and the atrial potassium channel I KACh . Molecular mechanisms regulating this critical signal transduction pathway are not fully understood.
C ardiac output is shaped to a great extent by sympathetic and parasympathetic influences. Parasympathetic input tempers heart rate (HR), counteracts the proarrhythmic effects of sympathetic activation, and is mediated by acetylcholine (ACh). 1 ACh is released from postganglionic parasympathetic neurons and binds to m 2 muscarinic receptors (m 2 Rs) on pacemaker cells and atrial myocytes, triggering activation of pertussis toxin-sensitive (Gi/o) heterotrimeric G proteins. 2 Once activated, G proteins dissociate into G␣-GTP and G␤␥ subunits, leading to modulation of adenylyl cyclase and multiple ion channels. Central among these reactions is the binding of G␤␥ to the atrial potassium channel I KACh , a heterotetramer composed of G protein-gated inwardly rectifying K ϩ (Girk)1 and Girk4 channel subunits. 3 Binding of G␤␥ to I KACh enhances its gating, which leads to cell hyperpolarization and, ultimately, decreased HR. 4 The duration of G protein signaling is controlled by members of the RGS (regulator of G protein signaling) family. 5 RGS proteins stimulate inactivation of G␣-GTP, facilitating its reassembly with G␤␥. RGS proteins play a critical role in shaping bradycardic effects of m 2 R receptor activation. 6 -8 Indeed, eliminating RGS influence by expressing G␣ subunits insensitive to RGS action results in a substantial enhancement of I KACh regulation by m 2 R signaling, via both G␣ o and G␣ i2 pathways. 7, 8 Although more than 30 RGS proteins have been identified, the involvement of specific RGS proteins in the regulation of parasympathetic input is not fully understood. Here, we report an unexpected role of the Rgs6/G␤5 complex, previously thought to be neuron-specific regulator, in the temporal regulation of m 2 R-I KACh signaling. I). Rgs6 protein was enriched in atria, where it was found predominantly in myocytes (Online Figure II) , consistent with a recent report, 9 and similar to the distribution of Girk1, an integral subunit of I KACh ( Figure 1B ). To begin exploring the role of Rgs6 in cardiac physiology, we obtained Rgs6 Ϫ/Ϫ mice where exons 5 to 7 encoding the critical N-terminal portion of the protein were eliminated ( Figure 1C and 1D) . Immunoblotting verified the complete absence of Rgs6 protein in the hearts of Rgs6 Ϫ/Ϫ mice ( Figure 1E ). Rgs6 interacts with the type 5 G protein ␤ subunit (G␤5) and the R7 binding protein (R7BP) in the CNS ( Figure 1F ). 10 In the mouse heart, however, only G␤5 is available for the interaction with Rgs6 ( Figure 1E ). Rgs6 was undetectable in hearts from G␤5 Ϫ/Ϫ mice, indicating that the physical association with G␤5 is critical for the expression and/or stability of Rgs6 ( Figure 1G ). Similarly, G␤5 levels were dramatically reduced in the Rgs6 Ϫ/Ϫ heart but not brain, indicating that in the heart Rgs6 is the predominant RGS bound to G␤5. No effect on Rgs6 or G␤5 levels was observed on elimination of R7BP or Girk4. Notably, we detected no compensatory changes in either G␣i/o proteins or RGS4, a protein previously implicated in regulation of the m 2 R-I KACh signaling. 6 Given the coenrichment of Rgs6 and I KACh in atria and the role of R7 RGS/G␤5 complexes in G protein-coupled receptor-GIRK signaling in the CNS, 11 we next measured the impact of Rgs6 ablation on m 2 R-I KACh signaling in neonatal atrial myocytes, which exhibit robust inward current triggered by the nonselective muscarinic agonist carbachol (CCh). Whereas CCh evoked currents with comparable potency in atrial myocytes from wild-type mice, current deactivation kinetics were notably slower across all CCh concentrations tested in myocytes from Rgs6 Ϫ/Ϫ mice (Online Figure III) .
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ACh acetylcholine Current activation kinetics were also delayed in Rgs6
Ϫ/Ϫ myocytes, although only for the lower CCh concentrations tested.
We next compared CCh-induced currents in sinoatrial node (SAN) cells, the key anatomic substrate for parasympathetic control of heart rate ( Figure 2 ). Although some differences in the density and kinetics of CCh-induced responses between adult SAN cells and neonatal atrial myocytes were evident, Rgs6 ablation correlated with significantly delayed deactivation rates in both cell types. Under the same conditions, no differences in CCh-induced steady-state current density or activation kinetics were observed between genotypes in either atrial myocytes or SAN cells (Figure 2 ). Furthermore, deletion of the G␤5 replicated prolonged deactivation kinetics seen in Rgs6 Ϫ/Ϫ myocytes ( Figure 2E ), indicating that regulation of the m 2 R-I KACh signaling in heart atria is mediated by the Rgs6/G␤5 complex rather than Rgs6 by itself.
The striking impact of Rgs6 ablation on m 2 R-I KACh signaling kinetics in atrial myocytes and SAN cells prompted us to test whether Rgs6/G␤5 can physically associate with the I KACh channel. In transfected HEK293 cells, we detected robust coimmunoprecipitation of the Rgs6/G␤5 complex with Girk4 but not Girk1 by both forward and reverse precipitation strategies (Figure 3) . Thus, the involvement of Rgs6/G␤5 in m 2 R-I KACh signaling is likely aided by a direct proteinprotein interaction mediated by the cardiac-specific Girk subunit Girk4.
The delay in I KACh deactivation kinetics triggered by Rgs6/G␤5 elimination is expected to enhance m 2 R-I KACh signaling because the channel would stay open longer, which would potentiate the parasympathetic regulation of HR. We addressed this possibility by analyzing cardiac function in mice using ECG telemetry, at baseline and following pharmacological manipulation. Analysis of ECG traces did not reveal gross abnormalities in cardiac physiology in Rgs6 Ϫ/Ϫ mice ( Figure 4A and Online Figure IV) . Rgs6 Ϫ/Ϫ mice did, however, display a mild resting bradycardia (511Ϯ13 versus 476Ϯ4 bpm, PϽ0.05), consistent with the effect of Rgs6/ G␤5 ablation on m 2 R-dependent signaling in atrial myocytes ( Figure 4B ). Although CCh administration (0.1 mg/kg, IP) triggered a rapid decrease in HR in wild-type and Rgs6 Ϫ/Ϫ animals, the effect was significantly larger and persisted longer in Rgs6 Ϫ/Ϫ mice ( Figure 4C ). Similarly, parasympathetic blockade with atropine (1 mg/kg, IP) had a positive chronotropic effect in both groups, with a significantly larger effect seen in Rgs6 Ϫ/Ϫ mice ( Figure 4D ). Importantly, there was no difference in HR immediately following atropine administration, indicating that the bradycardia seen in Rgs6 Ϫ/Ϫ mice results from enhanced intrinsic m 2 R signaling.
Discussion
Here, we report that Rgs6/G␤5 negatively regulates m 2 R-I KACh signaling in atrial myocytes by accelerating I KACh deactivation kinetics. These observations, together with the effect of Rgs6 ablation on HR and responses to pharmacological manipulation, indicate that Rgs6/G␤5 represents a key node of regulation in the parasympathetic control of cardiac output. Because dysregulation of the parasympathetic tone by deficiencies in I KACh function is increasingly accepted as a major factor in the pathogenesis of the atrial fibrillation, 1 our study introduces Rgs6/G␤5 complex as an attractive candi- RGS6/G␤5 forms a complex with Girk4. Rgs6 and G␤5 were coexpressed with either AU1-tagged Girk4 or AU5-tagged Girk1 in HEK293 cells. Forward and reciprocal coimmunoprecipitation assays were performed as described in the Online Methods using indicated antibodies. Eluates were analyzed using Western blotting.
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date for better understanding of cardiac pathophysiology and development of corrective therapies. Rgs6 belongs to the R7 family of RGS proteins, members of which were thought to be expressed exclusively in the nervous system, where they play roles in nociception, vision, reward behavior and locomotion. 10 Although Rgs6 expression was reported previously in the heart, 9,12,13 our study documents for the first time the functional relevance of Rgs6 to cardiac physiology. In the CNS, Rgs6 forms complexes with 2 proteins, G␤5 and R7BP, that specify its stability, subcellular distribution, and activity. 10 Here, we show that cardiac Rgs6 forms a complex with G␤5, but not with R7BP which is undetectable in the heart. The obligate and functionally relevant nature of the Rgs6/G␤5 interaction was underscored by the mutual dependence of Rgs6 and G␤5 levels on their coexpression and the phenotypic similarities in m 2 R-I KACh signaling in myocytes from Rgs6 Ϫ/Ϫ and G␤5 Ϫ/Ϫ mice. In neurons, G␤5 recruits R7 RGS proteins to GIRK channels, resulting in accelerated channel kinetics associated with GABA B receptor activation. 11 Thus, the present work reveals the conservation of this compartmentalization mechanism by showing that Rgs6/G␤5 can likewise regulate m 2 R-I KACh signaling.
Previous work has identified Rgs4 as a critical regulator of m 2 R-I KACh signaling in sinoatrial nodal cells. 6 Indeed, the deficiencies in m 2 R-I KACh signaling linked to Rgs6 ablation reported herein are reminiscent of those reported in Rgs4 Ϫ/Ϫ mice. 6 Therefore, murine sinoatrial nodal cells may use parallel approaches involving Rgs4 and Rgs6/G␤5 to regulate m 2 R-I KACh signaling. It is possible, for example, that Rgs4 and Rgs6/G␤5 selectively regulate different G protein subtypes involved in I KACh gating. Indeed, studies with knock-in mice expressing RGS-insensitive G proteins reveal a differential contribution of G␣ i2 and G␣ o to m 2 R-dependent actions. 7, 8 Furthermore, Rgs6/G␤5 shows selectivity toward G␣ o over G␣ i2 in vitro. 14 However, whereas the role of G␣ i2 in mediating m 2 R-I KACh coupling is well established, 8 the involvement of G␣ o in this process is less certain. Moreover, it remains possible that other proteins of the more than 30-member RGS family also play roles in this regulation. Delineating the mechanisms of the functional involvement of RGS proteins in controlling m 2 R-I KACh signaling in the mouse models and their relevance to human physiology will serve as an exciting direction for future research. 
Novelty and Significance
What Is Known?
• Activation of the parasympathetic branch of the autonomic nervous system decreases heart rate via the neurotransmitter acetylcholine.
• Acetylcholine stimulates m2 muscarinic receptors (m2Rs) on sinoatrial nodal cells and atrial myocytes, leading to the G proteindependent activation of the potassium channel I KACh.
• Modulating m2R-I KACh signaling can impact heart rate.
What New Information Does This Article Contribute?
• The Rgs6/G␤5 protein complex is an essential modulator of m2R-I KACh signaling in cardiac myocytes and sinoatrial cells.
• Inactivation of the Rgs6 gene in mice results in a mild bradycardia and an enhanced effect of drug-induced parasympathetic stimulation.
m2R-I KACh signaling plays a critical role in controlling heart rate and has been implicated in the pathogenesis of atrial fibrillation. The molecular mechanisms regulating this process, however, are not fully understood. Here, we identify the Rgs6/G␤5 protein complex as a key regulator of m2R-I KACh signaling in cardiomyocytes and sinoatrial cells. We show that Rgs6/G␤5 can physically associate with I KACh and that deletion of the Rgs6 gene in mice significantly enhances the parasympathetic regulation of heart rate. Thus, Rgs6/G␤5 may contribute to, or represent a novel therapeutic target for, pathological conditions characterized by abnormal regulation of cardiac output.
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SUPPLEMENT MATERIAL METHODS
Antibodies, Recombinant Proteins, DNA Constructs. Sheep anti-RGS6 antibodies (α-RGS6-FL) were generated against recombinant fragment containing amino acids 263-472 of mouse RGS6 that was expressed and purified from E.coli as described 1 . Antibodies were affinity-purified on the epitopeconjugated column and stored in PBS buffer containing 50% glycerol. Rabbit anti-Gβ5 (SGS) and rabbit anti-R7BP (TRS) antibodies were a generous gift from Dr. William Simonds, NIDDK. Rabbit polyclonal anti-AU1 tag (GenScript, Piscataway, NJ), mouse monoclonal anti-AU5 (MMS-135R; Covance, Princeton, NJ), goat polyclonal anti-RGS4 (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal anti-PSD95 (Millipore, Billerica, MA) rabbit polyclonal anti-Gαi 1/2 (Thermo Fisher Scientific, Rochford, IL) and rabbit polyclonal anti-Gα o (K20; Santa Cruz Biotechnology, Santa Cruz, CA) were purchased. All general chemicals were purchased from Sigma Aldrich (St. Louis, MO).
Cloning of full-length mouse Gβ5S and RGS6 was described previously 2, 3 . The open reading frame of Gβ5S was subcloned into pcDNA3.1/TOPO (Invitrogen) mammalian expression vector, and Rgs6 was cloned into pcDNA3.1NT-GFP-TOPO (Invitrogen) creating an N-terminal fusion with GFP. Cloning of Girk1-AU5 and Girk4-AU1 into mammalian expression vectors has been described 4 . All constructs were propagated using an E.coli Top-10 strain (Invitrogen), isolated using Nucleobond kits, (Macherey-Nagel; Bethlehem, PA) and sequenced.
Mouse Strains. The generation of R7bp
-/-5 , Gβ5 -/-6 , and Girk4 -/-7 mice has been described previously.
Gβ5
-/-mice were generously provided by Dr. Jason Chen (Virginia Commonwealth University). These three strains of mice were out-bred onto the C57BL/6 background for at least 5 generations. Rgs6 -/-mice were generated by Lexicon Pharmaceuticals using 129SvEvBrd embryonic stem cells. Chimeric offspring were mated with C57BL/6 strain and the resulting heterozygous progeny were inbred to generate null mutant and wild-type littermates. Mice were housed in groups on a 12h light/dark cycle with food and water available ad libitum. All procedures were carried out in accordance with the National Institute of Health guidelines and were granted formal approval by the Institutional Animal Care and Use Committee of the University of Minnesota. All efforts were made to minimize the use of animals in this study, as well as their suffering. All animals used in this study were bred on-site.
Cell culture and transfections. HEK293FT cells were obtained from Invitrogen (Carlsbad, CA) and cultured at 37°C and 5% CO 2 in DMEM (Dulbecco's Modified Eagle Medium; GIBCO) supplemented with 100 units of penicillin and 100 mg of streptomycin, 10% FBS, 1x MEM non-essential amino acids (GIBCO; Carlsbad, CA), 1 mM sodium pyruvate and 4 mM L-glutamine. Cells were transfected at ~70% confluency, using Lipofectamine LTX (Invitrogen) according to the manufacturer's protocol. The ratio of Lipofectamine to DNA used was 6.25 μl : 2.5 μg per 10 cm 2 cell surface. Cells were grown for 24-48 hours post-transfection. Equal amounts of each construct were transfected, balanced when necessary by empty pcDNA3.1 vector.
Immunoprecipitation assays and Western blotting. Cellular and tissue lysates were prepared in immunoprecipitation (IP) buffer (1XPBS (Fisher Scientific), 150 mM NaCl, 1% Triton X-100, protease inhibitors (Roche; Indianapolis, IN) and centrifuged for 15 min at 14,000 x g. Protein concentration was determined in the resulting extracts using BSA assay (Pierce; Rockford, IL) and equal amounts of protein were incubated with 3 μg of antibodies and 10 μl of protein G beads (GE Healthcare; Waukesha,WI) for 1 h at 4 0 C. After 3 washes with ice-cold IP buffer proteins bound to the beads were eluted with SDSsample buffer. Eluates were resolved on 12.5% SDS-PAGE gel, transferred onto PVDF membrane (Millipore (Billerica, MA)) and subjected to Western blot analysis using HRP conjugated secondary antibodies and an ECL West Pico (Pierce) detection system. For quantification, samples were analyzed by infrared Western blotting using IRDye680 and IRDye800 labeled secondary antibodies (Li-Cor Biosciences; Lincoln, NE) according to the manufacturer's protocol. Detection and quantification of specific bands was performed on an Odyssey Infrared Imaging System (Li-Cor Biosciences). The integrated intensity of each band of interest was measured in a corresponding channel with a top-bottom background setting. Whole-cell electrophysiology. Primary cultures of atrial myocytes were generated from neonatal mice (P2-4) as described 8, 9 , using the Neonatal Cardiomyocyte Isolation System (Worthington Biochemical Corp., Lakewood, NJ). Atrial myocytes were used for electrophysiological analysis after 1-3 d in culture. Sinoatrial nodal cells were isolated from adult mice (3 months) as described 10 , and used within 8 h of isolation. In brief, hearts were excised into Tyrode's solution (in mM): 140 NaCl, 5.4 KCl, 1.2 KH 2 PO4, 1.0 MgCl 2 , 1.8 CaCl 2 , 5.5 glucose, 5 HEPES, pH 7.4 with NaOH. The sinoatrial node (SAN) was identified as the narrow band of tissue located on the inner wall of the right atrium, medial to the crista terminalis and between the superior and inferior vena cava. Two incisions were made to the superficial side of the superior and inferior vena cava, followed by a longer cut along the outer atrial wall, to expose the SAN region. SAN-containing tissue was excised into a modified Tyrode's solution containing (in mM): 140 NaCl, 5.4 KCl, 1.2 KH 2 PO 4 , 0.2 CaCl 2 , 50 taurine, 18.5 glucose, 5 HEPES, 0.1% BSA, pH 6.9 with NaOH, with elastase (0.3 mg/ml; Worthington Biochemical Corp.) and collagenase II (0.21 mg/ml; Worthington Biochemical Corp.). SAN tissue was digested at 37°C for 30 min, with occasional inversion, and then washed three times in a solution containing (in mM): 100 L-glutamic acid/potassium salt, 10 L-aspartic acid/potassium salt, 25 KCl, 10 KH 2 PO 4 , 2 MgSO 4 , 20 taurine, 5 creatine, 0.5 EGTA, 20 glucose, 5 HEPES, 0.1% BSA, pH 7.2 with KOH. SAN tissue was then triturated in the wash solution and plated onto poly-L-lysine coated coverslips for electrophysiological studies.
Adult cardiomyocyte isolation.
Coverslips containing atrial myocytes or SAN cells were transferred to a chamber containing a low-K + bath solution (in mM): 140 NaCl, 4 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 D-glucose, 10 HEPES/NaOH (pH 7.4). Cardiac cells were visualized using an Olympus IX-70 microscope. The dominant population of atrial myocytes with spherical shape (typical capacitance, 10-20 pF) was targeted for this study. SAN cells were identified as the thin striated cells exhibiting spontaneous contractions (typical capacitance, 25-40 pF) (see Fig. 2A, inset) . Membrane potentials and whole-cell currents were measured with hardware (Axopatch-200B amplifier, Digidata 1320) and software (pCLAMP v. 9.2) from Molecular Devices (Sunnyvale, CA). Borosilicate patch pipettes (3-5 MΩ) were filled with (in mM): 130 gluconate, 2 MgCl 2 , 1.1 EGTA/KOH (pH 7.2), 5 HEPES/KOH (pH 7.2), 2 Na 2 ATP, 5 phosphocreatine, 0.3 Na-GTP.
Upon achieving whole-cell access, input resistance, capacitance, and resting membrane potentials were measured. Neonatal atrial myocytes and SAN cells from wild-type and knockout mice did not differ with respect to these parameters. CCh-induced currents were measured at a holding potential of -70 mV using a high-K + bath solution (in mM): 120 NaCl, 25 KCl, 2 CaCl 2 , 2 MgCl 2 , 10 D-glucose, 10 HEPES/NaOH (pH 7.4). The high-K + bath solution (+/-CCh) was applied with an SF-77B rapid perfusion system (Warner Instruments, Inc.; Hamden, CT). In pilot studies, we found no difference in current amplitudes evoked by 10 and 100 μM CCh, irrespective of genotype or cell type. As such, 10 μM CCh was taken as the saturating CCh concentration for these studies. All currents were low-pass filtered at 1 kHz, sampled at 2 kHz, and stored on computer hard disk for analysis. Steady-state current amplitudes were measured for each experiment by subtracting the baseline current from the current measured just prior to the return to drug-free solution. Activation and deactivation time constants were extracted from appropriate regions of current traces, which were fit with a 1-term Boltzmann equation using the Levenberg-Marquardt search method, sum of squared errors minimization method, and no weighting (Online Fig. V) . Only those experiments for which the access resistances were stable and low (<15 MΩ) were included in the final analysis.
Telemetry. Wild-type (n=5) and Rgs6
-/-(n=5) littermates aged 4-5 months were used for in vivo ECG monitoring. Biopotential telemetry transmitters ETA-F10 (Data Sciences International; Saint Paul, MN) were implanted intraperitoneally under kethamine/xylazine anesthesia (60 and 12 mg/kg correspondently). ECG leads were externalized and abdominal wall was closed with Prolene 5-0 (Ethicon; Somerville, NJ) incorporating suture rib of the transmitter into the closure. ECG leads were tunneled under the skin into lead II position and sutured to the abdominal wall by Prolene 5-0. Skin incisions were closed using Vicryl 5-0 (Ethicon). Upon termination of anesthesia, animals received a single intraperitoneal injection of ketoprofen (5 mg/kg), followed by administration of ibuprofen and amoxicillin in drinking water during recovery period (days 1-10). Upon recovery, recordings were performed in a scheduled manner, for 20 s each min, following 1-h acclimation using Dataquest ART 4.2 acquisition software (Data Sciences International). On day 11, 6 h of baseline ECG data were recorded. On day 12, after 30 min of baseline recording, animals were injected i.p. with 0.9% saline solution (10 ml/kg) as a vehicle control. Atropine sulfate was injected 2 h later (1 mg/kg, i.p.; Hospira, Lake Forest, IL), followed by 3 h of recording. On day 13, following 30 min of baseline recording, animals were injected first with 0.9% saline solution and 2 h later with CCh (0.1 mg/kg, i.p.; Acros Organics, Geel, Belgium). Recording proceeded for 3 h, after which animals were sacrificed by CO 2 inhalation. Transmitters were explanted, cleaned with 1% Tergazyme enzymatic detergent (Alconox; White Plains, NY), sterilized with Cidex activated dialdehyde solution (Ethicon), and reused.
Statistical Analysis. Statistical analyses were performed using Prism (GraphPad Software, Inc.; La Jolla, CA) and SigmaPlot 11 (Systat Software Inc; San Jose, CA). EC 50 values were calculated with the Hill coefficient set to 1. The impact of genotype on CCh-induced current responses (steady-state current density and kinetics) was evaluated using one-way (single-saturating concentration study) and two-way (concentration-response study) ANOVA. The impact of genotype on CCh-and atropine-induced heart rate response was evaluated using two-way (time-response study) ANOVA. Tukey's Multiple Comparison (one-way ANOVA) and Bonferroni (two-way ANOVA) post hoc tests were used as appropriate. For all analyses, the level of significance was set at P < 0.05. Figure 1A have been determined by densitometry using Image J software and normalized to the total protein content determined from CBB stained gel ( Figure 1A) . Resulting values representing relative abundance of Rgs6 proteins across tissues are plotted as a bar graph.
Online Figure II . Rgs6 is present in isolated atrial cardiomyocytes. Cardiomyocytes were isolated from adult mice as described in Methods section above. Following lysis in SDS sample buffer, 25 μg of total protein was loaded on the gel. Rgs6 expression was detected by Western blotting with specific antiRgs6-FL antibodies. Brain tissue was used as a control. The absence of the immunoreactivity for the neuronal specific marker PSD95 in isolated cardiomyocyte fraction (CM) demonstrate that Rgs6 is predominantly expressed in the myocytes. Protein loading was verified by Coomasie Brilliant Blue (CBB) following separation on SDS-PAGE gel. Densitometric analysis of the total protein content quantified from the CBB-stained gel is presented in the lower panel. 
